Private Label Male Health Manufacturer | T + Prostate + Performance Stacks

The global mens health supplement market is tracking past $50 billion by 2028, with testosterone support, prostate, and sexual performance the three categories driving the curve. Before you write a single line of formula brief, pick your sub-segment. There are six clean lanes a founder can own: T-booster (energy, lean mass, vitality positioning), prostate (BPH-adjacent, 40+ demographic), performance and libido (drive, stamina, vascular support), hair retention (DHT-modulating stack), fertility (motility, count, conception support), and cardiovascular (lipid, blood pressure, vascular health for men 50+). Each lane has its own consumer language, its own channel fit, and its own compliance landmines. Brands that try to cover all six in one SKU end up with a 12-ingredient kitchen sink that under-doses every active. We will help you pick one lane to launch with, build a defensible stack inside it, then layer adjacent SKUs on the reorder curve. That is how mens brands scale past the first 5,000 bottles.

On testosterone and performance, the literature is clear which actives carry the clinical signal. For T-booster stacks we lead with KSM-66 ashwagandha at 600mg (the most-studied root extract on serum testosterone and cortisol), Testofen fenugreek standardized to 50% Fenuside at 600mg (the Gencor branded ingredient with peer-reviewed free T data), Furosap fenugreek seed extract at 500mg as a glycoside-rich alternative, D-aspartic acid at 3g, zinc bisglycinate at 30mg, and vitamin D3 at 5000 IU. For libido and performance we layer in Eurycoma longifolia (Tongkat Ali) standardized to 22% bio-active eurypeptides such as LJ100 at 200mg, maca root 4:1 extract at 1500mg, tribulus terrestris standardized to 90% saponins at 750mg, plus L-citrulline 6g and L-arginine 3g for nitric oxide and vascular support. Branded actives carry a 15-40% ingredient cost premium over generic equivalents, and they buy you two things: documented clinical evidence you can cite in marketing copy, and a moat against the dozen lookalike brands running unstandardized extracts.

Prostate and fertility are the older, calmer lanes with longer reorder cycles and lower competition. Prostate stacks center on saw palmetto berry extract standardized to 85% fatty acids at 320mg (the dose used in the BPH literature), pygeum africanum bark extract at 100mg, stinging nettle root extract at 250mg, lycopene 10mg, beta-sitosterol 300mg, and zinc bisglycinate 30mg. This is a 40+ demographic, often a once-a-day capsule, sold heavily on Amazon and through urology-adjacent DTC funnels. Fertility stacks target sperm motility, count, and morphology with CoQ10 (ubiquinol form preferred) at 200mg, L-carnitine tartrate at 1000mg, zinc 25mg, vitamin C 1000mg, vitamin E 200 IU, selenium 200mcg, omega-3 EPA/DHA 1g, plus KSM-66 ashwagandha 600mg for the stress and sperm-quality crossover data. Fertility skews to couples-trying-to-conceive demographics with a six-to-nine month consumption window, which makes the lifetime value strong even at single-bottle margins. Both lanes reward thoughtful labeling more than aggressive claims.

Now the compliance section, because male health is the FTC and FDA enforcement hotspot. Supplements live under structure-function rules: you can say a formula 'supports healthy testosterone levels within the normal range,' 'supports prostate function,' 'supports healthy libido,' or 'supports sperm health.' You cannot say a supplement 'treats low testosterone,' 'cures BPH,' 'restores erections,' 'reverses erectile dysfunction,' or 'increases testosterone by X%' without a substantiating clinical trial on your finished formula. Erectile dysfunction, BPH, hypogonadism, prostate cancer, and male infertility are all DISEASE states regulated as drug indications, and any claim that implies treatment, cure, mitigation, or prevention crosses the line. The defensible language pattern is: target a structure or function ('libido,' 'stamina,' 'blood flow,' 'free testosterone within normal range,' 'urinary flow comfort'), use 'supports' or 'helps maintain,' add the FDA disclaimer, and substantiate every numeric or comparative claim with the underlying clinical citation on the ingredient at your dose. Our regulatory team reviews every customer label before production and rewrites any phrase that would draw an FTC warning letter. That review is included in the 4-6 week onboarding.